Demystifying the Science behind Targeted Treatments and Immunotherapies for Bowel Cancer Virtual Study Day
In this course Dr Elaine Vickers provides an up-to-date overview of bowel cancer biology and genetics and the science behind various treatment approaches.
Event: Study day
These include monoclonal antibodies targeting EGFR, and small molecule such as B-Raf inhibitors. She also describes the rationale behind checkpoint inhibitors for selected patients, and treatment approaches in trials.
DAY 2 - TT and Immunotherapies for Bowel Cancer_0.pdf
Science Communicated events calendar 2021-2023_0.pdf